Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors

[1]  M. Lefranc.  IMGT, the International ImMunoGeneTics Information System. , 2011, Cold Spring Harbor protocols.

[2]  S. Tangye,et al.  Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients. , 2008, Blood.

[3]  Michael Hallek,et al.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.

[4]  S. Tyring,et al.  Herpesvirus prevalence and viral load in healthy blood donors by quantitative real‐time polymerase chain reaction , 2008, Transfusion.

[5]  R. Rosenquist,et al.  A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. , 2008, Blood.

[6]  K. Stamatopoulos,et al.  Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IgG-switched stereotyped immunoglobulins , 2008, Haematologica.

[7]  N. Caporaso,et al.  Acquired immune‐related and inflammatory conditions and subsequent chronic lymphocytic leukaemia , 2007, British journal of haematology.

[8]  Nikolaos Laoutaris,et al.  Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. , 2007, Blood.

[9]  N. Caporaso,et al.  Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. , 2007, Blood.

[10]  E. Meffre,et al.  B-Cell Chronic Lymphocytic Leukemia (B-CLL) Cells Express Antibodies Reactive with Antigenic Epitopes Expressed on the Surface of Common Bacteria. , 2006 .

[11]  Nikolaos Laoutaris,et al.  Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. , 2006, Blood.

[12]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[13]  T. F. Smith,et al.  Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing , 2006, Clinical Microbiology Reviews.

[14]  J. Harley,et al.  Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus , 2006, Autoimmunity.

[15]  H. Döhner,et al.  Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. , 2005, Blood.

[16]  Nikolaos Laoutaris,et al.  Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. , 2005, Blood.

[17]  E. Milner,et al.  Human innate B cells: a link between host defense and autoimmunity? , 2005, Springer Seminars in Immunopathology.

[18]  Göran Roos,et al.  Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. , 2004, Blood.

[19]  J. Gribben,et al.  Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. , 2004, Blood.

[20]  Steven L. Allen,et al.  Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia , 2004, The Journal of experimental medicine.

[21]  L. Chiriboga,et al.  Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. , 2004, Blood.

[22]  Marie-Paule Lefranc,et al.  IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor VJ and VDJrearrangement analysis , 2004, Nucleic Acids Res..

[23]  Anna Tramontano,et al.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. , 2004, The Journal of clinical investigation.

[24]  A. Cappione,et al.  Lupus IgG VH4.34 Antibodies Bind to a 220-kDa Glycoform of CD45/B220 on the Surface of Human B Lymphocytes1 , 2004, The Journal of Immunology.

[25]  D. Isenberg,et al.  Common Patterns of B Cell Perturbation and Expanded V4-34 Immunoglobulin Gene Usage in Autoimmunity and Infection , 2004, Autoimmunity.

[26]  G. Juliusson,et al.  Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. , 2003, Blood.

[27]  G. Guida,et al.  The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. , 2003, Blood.

[28]  Y. Jang,et al.  Anti-DNA antibodies: aspects of structure and pathogenicity , 2003, Cellular and Molecular Life Sciences CMLS.

[29]  M. Weigert,et al.  Anti–DNA B Cells in MRL/lpr Mice Show Altered Differentiation and Editing Pattern , 2002, The Journal of experimental medicine.

[30]  B. Sutton,et al.  Evidence for Involvement of a Hydrophobic Patch in Framework Region 1 of Human V4-34-Encoded Igs in Recognition of the Red Blood Cell I Antigen1 , 2002, The Journal of Immunology.

[31]  P. Moss,et al.  Cytomegalovirus Seropositivity Drives the CD8 T Cell Repertoire Toward Greater Clonality in Healthy Elderly Individuals1 , 2002, The Journal of Immunology.

[32]  M. Radic,et al.  Editors and editing of anti-DNA receptors. , 2001, Immunity.

[33]  A. Cappione,et al.  Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. , 2001, The Journal of clinical investigation.

[34]  M. McClain,et al.  The role of Epstein-Barr virus in systemic lupus erythematosus. , 2001, Frontiers in bioscience : a journal and virtual library.

[35]  G. Widhopf,et al.  Normal B Cells Express 51p1-Encoded Ig Heavy Chains That Are Distinct From Those Expressed by Chronic Lymphocytic Leukemia B Cells1 , 2001, The Journal of Immunology.

[36]  Stevenson,et al.  Recognition of Auto‐ and Exoantigens by V4‐34 Gene Encoded Antibodies , 2000, Scandinavian journal of immunology.

[37]  K. Richards,et al.  VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics. , 1999, The Journal of rheumatology.

[38]  L. Rassenti,et al.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. , 1998, The Journal of clinical investigation.

[39]  J C Sacchettini,et al.  X-ray crystallographic studies of unique cross-linked lattices between four isomeric biantennary oligosaccharides and soybean agglutinin. , 1997, Biochemistry.

[40]  T. Marion,et al.  Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies. , 1996, Journal of immunology.

[41]  T. Kipps,et al.  The V4-34 encoded anti-i autoantibodies recognize a large subset of human and mouse B-cells. , 1996, Blood cells, molecules & diseases.

[42]  J. D. Capra,et al.  The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. , 1996, Journal of molecular biology.

[43]  C. Chapman,et al.  Pattern of Usage of the VH4–21 Gene by B Lymphocytes in a Patient with EBV Infection Indicates Ongoing Mutation and Class Switching a , 1995, Annals of the New York Academy of Sciences.

[44]  C. Chapman,et al.  Pattern of usage of the VH4-21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching. , 1995, Molecular immunology.

[45]  C. Chapman,et al.  Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells. , 1993, Journal of immunology.

[46]  J. D. Capra,et al.  VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. , 1992, Journal of immunology.

[47]  J. Paulson,et al.  Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type , 1984, Nature.

[48]  K. Stamatopoulos,et al.  ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia , 2007, Leukemia.

[49]  Yuh‐Cheng Yang,et al.  B cell lymphoproliferative disorders and VH4-34 gene encoded antibodies. , 2004, Human antibodies.

[50]  C. Chapman,et al.  A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1. , 1999, Human antibodies.

[51]  C. Chapman,et al.  Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene. A possible link between infection and lupus. , 1995, Annals of the New York Academy of Sciences.